Flu vaccines: ACIP brings back FluMist for the 2018-2019 flu season
by Press Release from Outbreak News Today on (#3GHY8)
AstraZeneca announced yesterday that the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has voted in favor of a renewed recommendation for the use of FLUMIST(R) QUADRIVALENT (Influenza Vaccine Live, Intranasal) in the US for the 2018-2019 season. The recommendation follows the presentation of positive results from a US ["]
The post Flu vaccines: ACIP brings back FluMist for the 2018-2019 flu season appeared first on Outbreak News Today.